Policy & regulation

The number of international health practitioners registered to work in Australia over the past year has almost doubled, according to...

The Optical Distributors and Manufacturers Association (ODMA) is disappointed free trade negotiations between Australia and the European Union (EU) have...

The US Food and Drug Administration (FDA) has issued product warnings for an additional 27 over-the-counter eyedrop products due to...

New data has highlighted “a concerning new trend” of older Australians aged 75 to 84 taking out private health insurance...

Ahpra is asking practitioners to renew their general, specialist or non-practising registration before the end-of-year deadline, as new data shows...

The Queensland parliament has passed a new law restricting use of the title ‘surgeon’ to doctors registered in one of...

Australian optometrists and ophthalmologists will face an increase in their registration fees for 2023/24, with eye doctors facing a $135...

The US Food and Drug Administration (FDA) issued warning letters to eight firms marketing unapproved ophthalmic drug products. These warnings...

The outbreak of a lethal drug-resistant bacteria strain linked to an alleged eye drop manufacturing breakdown is one of the...

The US FDA has approved the use of high dose Eylea (aflibercept) for three macular conditions, equating to longer intravitreal...